For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Astria Therapeutics Inc (NASDAQ: ATXS) closed the day trading at $12.47 down -0.56% from the previous closing price of $12.54. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.9 million shares were traded. ATXS stock price reached its highest trading level at $12.6 during the session, while it also had its lowest trading level at $12.45.
Ratios:
For a better understanding of ATXS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.89 and its Current Ratio is at 14.89. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 17, 2025, Reiterated its Buy rating but revised its target price to $20 from $16 previously.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $47.
On January 31, 2025, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $26.JMP Securities initiated its Mkt Outperform rating on January 31, 2025, with a $26 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 703743168 and an Enterprise Value of 544655104.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.26, which has changed by 0.039801 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $12.59, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is 49.43%, while the 200-Day Moving Average is calculated to be 90.66%.
Shares Statistics:
Over the past 3-months, ATXS traded about 1.50M shares per day on average, while over the past 10 days, ATXS traded about 7673900 shares per day. A total of 56.43M shares are outstanding, with a floating share count of 42.41M. Insiders hold about 24.86% of the company’s shares, while institutions hold 77.52% stake in the company. Shares short for ATXS as of 1760486400 were 4024158 with a Short Ratio of 2.69, compared to 1757894400 on 2941993. Therefore, it implies a Short% of Shares Outstanding of 4024158 and a Short% of Float of 8.979999.
Earnings Estimates
The stock of Astria Therapeutics Inc (ATXS) is currently being evaluated by 5 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.27 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$1.81 and -$2.53 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$2.38, with 4.0 analysts recommending between -$2.02 and -$2.75.
